Skip to main content
Fig. 3 | Biological Procedures Online

Fig. 3

From: Circadian gene CSNK1D promoted the progression of hepatocellular carcinoma by activating Wnt/β-catenin pathway via stabilizing Dishevelled Segment Polarity Protein 3

Fig. 3

The expression features and clinical implication of CSNK1D in HCC. A Expression characteristics of CSNK1D in different cancer types in TCGA database. B The expression levels of CSNK1D in GSE19665, GSE60502 and GSE62232. C CSNK1D expression in HCC patients at different subgroups. D The ROC of CSNK1D in different time periods and comparison with typical HCC markers. E Univariate and Multivariate Cox analyses of the clinicopathological factors in TCGA LIHC cohort. F, G Analysis of CSNK1D protein and mRNA expression in 8 matched pairs of HCC and adjacent tissues. H The representative immunohistochemical staining of CSNK1D in adjacent tissues and HCC tissues at different stages. I The overall survival and recurrence free survival of HCC patients with high or low CSNK1D expression identified by immunohistochemistry. **P < 0.01, ***P < 0.001, ****P < 0.0001

Back to article page